Interview with the President and CEO: Second Sight Medical Products Inc. (NASDAQ:EYES)
Will McGuire, President and Chief Executive Officer of Second Sight Medical Products, Inc., joined the company in August 2015 from Volcano Corporation, where he was President of Americas Commercial since 2014. Previously, since 2013, he was Senior Vice President and General Manager of Coronary Imaging, Systems and Program Management, and prior to that position, Mr. McGuire served as Vice President and General Manager of Patient Monitoring at Covidien. He previously served as President and Chief Executive Officer of AtheroMed, Inc., a venture-capital-backed peripheral atherectomy company, prior to which he was Chief Operating Officer at Spectranetics Corporation, a publicly traded medical device company. In addition, Mr. McGuire held various positions at Guidant Corporation from 1998 to 2005, including General Manager of Guidant Latin America; Director of U.S. Marketing for Vascular Intervention, or VI; Director of Global Marketing for VI; and Production Manager for Coronary Stents. Prior to 1998, Mr. McGuire held positions in finance and production at IVAC Medical Systems. A graduate of the Georgia Institute of Technology, Mr. McGuire received his MBA from the Kenan-Flagler Business School at the University of North Carolina at Chapel Hill. Profile
TWST: Let's start by introducing the company to readers with a bit of Second Sight's history and a snapshot of your business today.